Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.385 USD | -3.00% | -4.47% | -12.48% |
05-16 | Transcript : AIM ImmunoTech Inc., Q1 2024 Earnings Call, May 16, 2024 | |
04-29 | AIM ImmunoTech Says Safety Evaluation of First Dose Level of Pancreatic Cancer Study Completed | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
AIM IMMUNOTECH INC. | Bio Therapeutic Drugs | -3.00% | -4.47% | -12.48% | -22.85% | -93.25% | 19.59M |
- Stock Market
- Equities
- AIM Stock
- Charts AIM ImmunoTech Inc.
- Relative Strength Chart